Peer-to-peer (P2P) review
A live phone conversation between the prescribing physician and a plan medical director or pharmacy reviewer. Often overturns a denial in 15 minutes when the physician explains the clinical context.
What it is
Peer-to-peer review is a direct phone consultation between the prescribing physician and the plan's reviewing physician (or PharmD). It's often offered as an informal step before or alongside the written internal appeal. The reviewing professional has the authority to overturn or uphold the denial in real time based on the clinical conversation.
Who can use it
Prescribing physicians and (sometimes) other prescribers (NPs, PAs). Patients and family members cannot directly request a P2P — it must come from the clinician.
When to use it
After a denial when the plan offers peer-to-peer review and the treating clinician can concisely address the plan's stated rationale. Confirm the purpose, deadline, reviewer role, and whether the discussion preserves formal appeal rights before relying on it.
Steps
- Call the plan and request the P2P. The denial letter usually has a P2P request number. Calling first is often faster than written request.
- Prepare the clinical pitch (5 minutes). Diagnosis, guideline support, prior-therapy history, why this specific therapy now, what alternatives have been considered/tried/contraindicated.
- Get on the call yourself. Plans often try to put MAs or nurses through. The reviewing physician needs to talk to the prescribing physician — that's the leverage.
- Reference the published criteria. Most plans' published medical policies are searchable. Cite the specific policy section that supports the request.
- Document the outcome. If approved, get the authorisation number in writing immediately. If denied, ask for the written reason and proceed to formal internal appeal.
Key deadlines
| Requirement | Deadline |
|---|---|
| Typical P2P window | Within 24-72 hours of request, sometimes same-day for urgent |
| Decision authority | Real-time on the call |
Frequently asked questions
What is peer-to-peer (p2p) review?
Peer-to-peer review is a direct phone consultation between the prescribing physician and the plan's reviewing physician (or PharmD). It's often offered as an informal step before or alongside the written internal appeal. The reviewing professional has the authority to overturn or uphold the denial in real time based on the clinical conversation.
Who can use peer-to-peer (p2p) review?
Prescribing physicians and (sometimes) other prescribers (NPs, PAs). Patients and family members cannot directly request a P2P — it must come from the clinician.
When should I use peer-to-peer (p2p) review?
After a denial when the plan offers peer-to-peer review and the treating clinician can concisely address the plan's stated rationale. Confirm the purpose, deadline, reviewer role, and whether the discussion preserves formal appeal rights before relying on it.
Typical P2P window — Peer-to-peer (P2P) review?
Within 24-72 hours of request, sometimes same-day for urgent
Decision authority — Peer-to-peer (P2P) review?
Real-time on the call
Related
- ERISA §503ERISA §503 is the foundational federal appeal-rights statute for the ~135 million Americans on emplo
- Expedited (urgent) appealWhen standard appeal timelines would jeopardise life, health, or function. Federal law mandates 72-h
- External review (IRO)Independent Review Organization (IRO) review — a binding decision by an outside organization after i
- Federal IDR (No Surprises Act dispute resolution)Federal Independent Dispute Resolution for OUT-OF-NETWORK provider payment disputes after the No Sur
- Grievance (vs appeal)A grievance is a complaint about plan conduct — service, access, quality — that does NOT involve a c
Start your appeal
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com